Search is Powered by Google
Cancer / Oncology News

Speedier, More Precise Cancer Radiotherapy

Main Category: Cancer / Oncology
Also Included In: Radiology / Nuclear Medicine;  Medical Devices
Article Date: 08 May 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

The University of Alabama at Birmingham (UAB) this month became the first U.S. medical center to offer a speedier cancer radiation therapy. The new technique can turn a 20-minute radiotherapy session into a 90-second session for selected patients.

Additionally, the new therapy saves healthy human tissue from unwanted radiation exposure at rates that are the same or better than other radiotherapy techniques, according to doctors at the UAB Comprehensive Cancer Center.

The new therapy is called RapidArc, which is the next-generation of intensity-modulated radiation therapy (IMRT). Conventional IMRT was introduced in the 1990s as a way to deliver multiple beams of radiation to a tumor, and minimize damage to nearby healthy tissues. RapidArc is an advancement on the earlier technology with radiation delivery times up to eight times faster than conventional IMRT, said the system's manufacturer Varian Medical Systems, Inc.

"RapidArc is an important advance for us and our patients," said John Fiveash, M.D., an associate professor of radiation oncology at UAB and Cancer Center scientist. "Knowing that we can reduce delivery times to less than two minutes per day is important considering what cancer care involves emotionally and physically."

Varian technicians added the RapidArc capability to UAB's existing IMRT machine during the last week of April. The upgrades serve as a kind of guidance system, much like a jet's automatic pilot, so that IMRT delivery can happen during a single rotation of the machine's arm around the patient.

The first U.S. patient to be given the new therapy is an Alabama man with early-stage prostate cancer whose treatment started May 6, Fiveash said. Faster radiation delivery times reduce the chances that a slight move will affect the accuracy of the radiotherapy targeting. Also, it means patients spend less time and feel less discomfort in the treatment room, he said.

"We presently treat many patients with very complex treatment plans," said John Brinkerhoff, R.Ph., M.B.A., C.M.P.E., executive administrator of UAB's Department of Radiation Oncology. "We have a head and neck cancer plan that would normally require a patient to lie still for 20 minutes with their face in a cushioned stability mask. With RapidArc, they are required to remain still for only 90 seconds."

The new system incorporates powerful computers to help doctors arrive at a radiotherapy treatment strategy after pouring over thousands of biological and mathematical variables, including medical scans of each patient's tumor.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Troy Goodman
University of Alabama at Birmingham




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...